Check-Cap Ltd. (CHEK )

Currency in USD Disclaimer
$1.89 -$0.09 (-4.51%)
Open 11/17/2025
$1.85
$2.1
$0.56
$3.13

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol CHEK
  • Company Check-Cap Ltd.
  • Price $1.89
  • Changes Percentage -4.51
  • Change -0.089
  • Day Low $1.85
  • Day High $2.1
  • Year High $3.13
  • Year Low $0.56
  • Market Cap $10,844,654
  • Price Avg 50 EMA (D) $1.77
  • Price Avg 200 EMA (D) $1.02
  • Exchange NASDAQ
  • Volume 238,787
  • Average Volume 2,969,042
  • Open $1.85
  • Previous Close $1.98
  • EPS -4.3
  • PE -0.43
  • Earnings Announcement 2025-11-24 12:00:00
  • Shares Outstanding $5,850,906

Company brief: CHECK-CAP LTD. (CHEK )

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

CHEK Corporation News

MBody AI ($CHEK) Secures 98% Shareholder Approval to Become Leading Nasdaq Embodied AI Company

MBody AI ($CHEK) Secures 98% Shareholder Approval to Become Leading Nasdaq Embodied AI Company

November 17, 2025 at 1:35 pm ET

newsfilecorp.com -- Nasdaq-listed AI company gains overwhelming shareholder support for its transformational merger, positioning MBody AI ($CHEK) as a hardware-agnostic embodied intelligence leader ready to scale enterpr...

Income Statement